Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Found 28 studies with search of: | "Medarex" [Exact] |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Completed |
Comparison Study of MDX-010 (CTLA-4) Alone and Combined With DTIC in the Treatment of Metastatic Melanoma
|
||||
2 | Active, not recruiting |
Study of the Combination of MDX-060 With Gemcitabine, MDX-060 Combined With Dexamethasone, and Gemcitabine Alone in Hodgkin's Disease
|
||||
3 | Recruiting |
Study of the Safety of MDX-1342 in Combination With Methotrexate in Patients With Rheumatoid Arthritis
|
||||
4 | Recruiting |
A Dose Escalation Study of MDX-1411 to Treat Advanced or Recurrent Clear Cell Renal Cell Carcinoma
|
||||
5 | Active, not recruiting |
A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies
|
||||
6 | Recruiting |
A Phase 1b Study of MDX-1106 in Subjects With Advanced or Recurrent Malignancies
|
||||
7 | Recruiting |
Study of MDX-1342 in Patients With Chronic Lymphocytic Leukemia (CLL)
|
||||
8 | Completed |
Study of MDX-010 in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma
|
||||
9 | Recruiting |
Phase 1 Study of MDX-1401 in Patients With CD30-Positive Refractory/Relapsed Hodgkin's Lymphoma
|
||||
10 | Not yet recruiting |
Phase 1,Open Label,Dose-Escalation,Multidose Study in Relapsed/Refractory Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma
|
||||
11 | Active, not recruiting |
MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Melanoma
|
||||
12 | Recruiting |
Phase 1 Open Label Study of MDX-1105 in Subjects With Solid Tumors
|
||||
13 | Completed |
MDX-060 in Patients With Relapsed or Refractory Classic Systemic or Primary Cutaneous Anaplastic Large Cell Lymphoma
|
||||
14 | Recruiting |
A Study of MDX-1106 to Treat Patients With Hepatitis C Infection
|
||||
15 | Completed |
Study of MDX-010 in Stage IV Breast Cancer
|
||||
16 | Completed |
A Dose-Escalation Study of MDX-1100 in Patients With Active Ulcerative Colitis
|
||||
17 | Active, not recruiting |
Study of MDX-010 in Patients With Metastatic Hormone-Refractory Prostate Cancer
|
||||
18 | Recruiting |
A Study of MDX-1100 in Subjects With Active Ulcerative Colitis
|
||||
19 | Completed |
Comparison Study of MDX-010 (CTLA-4) Alone and Combined With Docetaxel in the Treatment of Patients With Hormone Refractory Prostate Cancer
|
||||
20 | Completed |
A Study of MDX-010 (BMS-734016) Administered With or Without Prophylactic Oral Budesonide
|
Previous Page | Studies Shown (1-20) | Next Page (21-28) |